Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGreene King Regulatory News (GNK)

  • There is currently no data for GNK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - GREENE KING PLC

12 Feb 2015 15:20

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose GREENE KING PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 11 February 2015
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SPIRIT PUB CO PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORD
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 1,349,981 0.62% 1,687,373 0.77%
(2) Cash-settled derivatives:
1,256,552 0.57% 183,768 0.08%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 2,606,533 1.19% 1,871,141 0.85%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ORD Purchase 107 8.4800 GBP
ORD Purchase 470 8.4350 GBP
ORD Purchase 504 8.4650 GBP
ORD Purchase 551 8.4490 GBP
ORD Purchase 653 8.4700 GBP
ORD Purchase 1,102 8.4550 GBP
ORD Purchase 1,235 8.4498 GBP
ORD Purchase 2,390 8.4450 GBP
ORD Purchase 2,625 8.4554 GBP
ORD Purchase 3,030 8.4500 GBP
ORD Purchase 3,268 8.4478 GBP
ORD Purchase 3,503 8.4535 GBP
ORD Purchase 5,142 8.4475 GBP
ORD Purchase 6,036 8.4495 GBP
ORD Purchase 6,611 8.4515 GBP
ORD Purchase 35,067 8.4541 GBP
ORD Purchase 36,823 8.4569 GBP
ORD Sale 7 8.4364 GBP
ORD Sale 107 8.4800 GBP
ORD Sale 463 8.4358 GBP
ORD Sale 470 8.4350 GBP
ORD Sale 479 8.4596 GBP
ORD Sale 504 8.4650 GBP
ORD Sale 653 8.4700 GBP
ORD Sale 1,020 8.4578 GBP
ORD Sale 1,102 8.4550 GBP
ORD Sale 1,582 8.4904 GBP
ORD Sale 1,858 8.4579 GBP
ORD Sale 1,958 8.4494 GBP
ORD Sale 3,030 8.4500 GBP
ORD Sale 4,347 8.4818 GBP
ORD Sale 4,699 8.4569 GBP
ORD Sale 5,941 8.4573 GBP
ORD Sale 8,690 8.4450 GBP
ORD Sale 10,080 8.4553 GBP
ORD Sale 16,815 8.4600 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
ORD SWAP Long 700 8.5028 GBP
ORD CFD Long 1,020 8.4578 GBP
ORD SWAP Long 1,026 8.4608 GBP
ORD SWAP Long 1,479 8.4815 GBP
ORD CFD Long 2,147 8.4531 GBP
ORD CFD Long 2,552 8.4601 GBP
ORD CFD Long 4,797 8.4502 GBP
ORD SWAP Long 5,161 8.4715 GBP
ORD CFD Long 5,283 8.4599 GBP
ORD CFD Long 5,941 8.4573 GBP
ORD SWAP Short 700 8.4471 GBP
ORD SWAP Short 1,196 8.4493 GBP
ORD SWAP Short 2,625 8.4554 GBP
ORD CFD Short 1,526 8.4504 GBP
ORD SWAP Short 4,400 8.4500 GBP
ORD SWAP Short 17,600 8.4576 GBP
ORD CFD Short 36,823 8.4569 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 12 Feb 2015
Contact name: Jay Supaya
Telephone number: 0207 773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2015

Date   Source Headline
21st Aug 20173:52 pmRNSDirector/PDMR Shareholding
11th Aug 20177:00 amRNSCHANGE OF CHIEF FINANCIAL OFFICER
3rd Aug 20174:34 pmRNSAnnual Financial Report
3rd Aug 20177:00 amRNSDirector/PDMR Shareholding
1st Aug 20173:45 pmRNSTotal Voting Rights
4th Jul 20174:00 pmRNSDirector/PDMR Shareholding
4th Jul 20174:00 pmRNSDirector/PDMR Shareholding
4th Jul 20179:42 amRNSAdditional directorship of Philip Yea
29th Jun 20174:07 pmRNSTotal Voting Rights
29th Jun 20177:00 amRNSPreliminary results for the 52 weeks to 30 April17
31st May 20174:54 pmRNSTotal Voting Rights
28th Apr 201710:23 amRNSTotal Voting Rights
31st Mar 20179:47 amRNSTotal Voting Rights
17th Mar 20172:35 pmRNSHolding(s) in Company
28th Feb 20178:59 amRNSTotal Voting Rights
10th Feb 20177:00 amRNSSTRONG CHRISTMAS TRADING
2nd Feb 20174:58 pmRNSDirector/PDMR Shareholding
2nd Feb 20174:03 pmRNSDirector/PDMR Shareholding
31st Jan 20171:52 pmRNSTotal Voting Rights
18th Jan 20171:55 pmRNSFinancial Calendar
30th Dec 201611:07 amRNSTotal Voting Rights
12th Dec 201612:07 pmRNSDirector/PDMR Shareholding
30th Nov 20169:04 amRNSTotal Voting Rights
30th Nov 20167:00 amRNSINTERIM RESULTS FOR THE 24 WEEKS TO 16 OCTOBER 16
8th Nov 201611:03 amRNSDirector/PDMR Shareholding - Replacement
31st Oct 20169:47 amRNSTotal Voting Rights
19th Oct 20167:00 amRNSAdditional Listing
11th Oct 20163:21 pmRNSDirector/PDMR Shareholding - Replacement
6th Oct 20163:35 pmRNSDirector/PDMR Shareholding
5th Oct 20167:00 amRNSAdditional Listing
30th Sep 20168:43 amRNSTotal Voting Rights
9th Sep 20165:57 pmRNSDirectorate Change
9th Sep 20165:39 pmRNSResult of AGM
9th Sep 20167:01 amRNSNEW NON-EXECUTIVE DIRECTOR
9th Sep 20167:00 amRNSTrading statement for the 18 weeks to 04 Sept 16
31st Aug 201610:38 amRNSTotal Voting Rights
8th Aug 20169:00 amRNSAnnual Financial Report
29th Jul 20163:36 pmRNSDirector/PDMR Shareholding
29th Jul 20167:55 amRNSTotal Voting Rights
7th Jul 20167:00 amRNSDirector/PDMR Shareholding
5th Jul 20163:31 pmRNSDirector/PDMR Shareholding
30th Jun 201612:05 pmRNSTotal Voting Rights
29th Jun 20167:00 amRNSPreliminary results for the 52 weeks to 01 May 16
31st May 201610:53 amRNSTotal Voting Rights
26th May 20162:05 pmRNSGreene King completes £300m secured bond issuance
13th May 201612:46 pmRNSPOTENTIAL SECURED FINANCING TAP
29th Apr 20168:49 amRNSTotal Voting Rights
31st Mar 201611:39 amRNSTotal Voting Rights
3rd Mar 20167:00 amRNSAdditional Listing
29th Feb 201610:28 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.